Blended Care for the Discontinuation of Benzodiazepine Use
NCT03937180 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 924
Last updated 2022-07-15
Summary
This study aims to compare two strategies performed by GPs to help patients taking benzodiazepines on a daily basis for at least six months to discontinue their use. The first strategy consists of the usual or standard support provided by the GP, which often starts with a discontinuation advice or letter, the second is blended support where face-to-face consultations with the GP are alternated with web-based self-learning by the patient.
Conditions
- Benzodiazepine Dependence
- Benzodiazepine Dependent
- Benzodiazepine Withdrawal
Interventions
- BEHAVIORAL
-
Blended care
An interactive e-learning programme delivered through a secured web-based platform for patients and general practitioners (GPs), blended with face-to-face contacts between the involved GP and patient.
- BEHAVIORAL
-
Usual care
General practitioners offering usual care are expected to follow the Belgian guidelines as described in the most recent online version of "Anxiety, stress and sleeping problems A toolbox for general practitioners." or "Sleeping pills and sedatives. How to assist your patients in the search for other solutions?" which are both available in French and Dutch.
Sponsors & Collaborators
-
Belgium Health Care Knowledge Centre
collaborator OTHER_GOV -
Universiteit Antwerpen
collaborator OTHER -
University Ghent
collaborator OTHER -
Vrije Universiteit Brussel
collaborator OTHER -
Université Libre de Bruxelles
collaborator OTHER -
Université de Liège
collaborator OTHER -
Kristien Coteur
lead OTHER
Principal Investigators
-
Catharina Matheï · KU Leuven
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-06-24
- Primary Completion
- 2021-07-30
- Completion
- 2021-08-02
Countries
- Belgium
Study Locations
More Related Trials
-
Baclofen to Prevent Agitation in Alcohol Addicted Patients in ICU
NCT02723383 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Baclofen on Marijuana Withdrawal and Relapse
NCT00373295 ·Status: COMPLETED ·Phase: PHASE2
-
Baclofen in Managing Acute Alcohol Withdrawal
NCT03293017 ·Status: UNKNOWN ·Phase: PHASE4
-
Treating Alcohol Withdrawal With Oral Baclofen
NCT00597701 ·Status: COMPLETED ·Phase: NA
-
Baclofen for Anxiety and Alcohol Use Disorder (AUD): an Open Label Study
NCT06835907 ·Status: RECRUITING ·Phase: NA
-
Combination of Naltrexone and Baclofen for Alcohol Dependence:A Pilot Study.
NCT00614328 ·Status: COMPLETED ·Phase: PHASE1
-
Reducing Concurrent Opioid-Benzodiazepine Prescriptions
NCT03887247 ·Status: UNKNOWN ·Phase: NA
-
Treatment of Alcohol Withdrawal in Hospital Patients
NCT00249366 ·Status: COMPLETED ·Phase: PHASE4
-
Passiflora Extract for Benzodiazepine Withdrawal
NCT03780595 ·Status: UNKNOWN ·Phase: PHASE4
-
Disulfiram Combined With Lorazepam for Alcohol Dependence and Anxiety Disorder
NCT00721526 ·Status: COMPLETED ·Phase: PHASE4
-
Therapeutic Massage to Manage Withdrawal Related Anxiety
NCT00992979 ·Status: COMPLETED ·Phase: PHASE2
-
Hemadsorption to Enhance Drug Elimination in Intoxications
NCT06922786 ·Status: RECRUITING ·Phase: NA
-
NAlmefene Versus Placebo in Addition to Treatment as Usual on Craving in Behavioural Addictions
NCT05540288 ·Status: RECRUITING ·Phase: PHASE3
-
Outpatient Psychotherapeutic Treatment for Alcohol Dependent Individuals With Comorbid Psychiatric Disorders
NCT02141789 ·Status: COMPLETED ·Phase: NA
-
Preventing Alcohol Withdrawal Syndrome With Oral Baclofen
NCT02052440 ·Status: TERMINATED ·Phase: PHASE3
-
Baclofen as Add-On to Standard Treatment of Alcohol- Dependent Patients
NCT01002105 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of High Dose Baclofen for Alcohol Dependence
NCT01980706 ·Status: COMPLETED ·Phase: PHASE2
-
Discontinuation of Hypnotics in Older Veterans
NCT03511209 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Baclofen for Maintenance of Abstinence in Alcohol Dependent Patients
NCT01738282 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With Anxiety
NCT00004373 ·Status: COMPLETED ·Phase: PHASE2
-
Combining Non-Invasive Brain Stimulation With Cognitive Behavioral Intervention in Substance Use Disorder
NCT02570763 ·Status: WITHDRAWN ·Phase: NA
-
Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine
NCT03788889 ·Status: WITHDRAWN ·Phase: PHASE4
-
Development of an Anxiety Sensitivity-Based Intervention for Substance Use and Anxiety Comorbidity
NCT02667015 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Tolerability of Baclofen for Alcohol Dependence
NCT00877734 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Baclofen for the Treatment of Alcohol Drinkers
NCT01604330 ·Status: COMPLETED ·Phase: PHASE2/PHASE3